Psycho-Babble Medication Thread 413985

Shown: posts 1 to 4 of 4. This is the beginning of the thread.

 

Anyone every try Pamelor / Nortriptyline?

Posted by Sammybabe on November 9, 2004, at 19:09:09

I just started this after a very unsuccessful long run of Effexor. Is Pamelor good? My doc said it was one of the older but stronger meds. Any side effects? weight gain? any advice is welcome.

 

Re: Anyone every try Pamelor / Nortriptyline? » Sammybabe

Posted by Ted Brosnan on November 10, 2004, at 9:26:58

In reply to Anyone every try Pamelor / Nortriptyline?, posted by Sammybabe on November 9, 2004, at 19:09:09

I have been taking it for souple of days now. It's amazing I experience no side effects at all!

I take 50mg on the morning and I don't feel any sedation during the day and I get to sleep well at night.

It unlike other AD. It doesn't cause more anxiety, insomnia, sexual side effects or sedation. I haven't noticed that it makes me eat more...

 

Re: Anyone every try Pamelor / Nortriptyline?

Posted by Bill LL on November 10, 2004, at 10:10:58

In reply to Anyone every try Pamelor / Nortriptyline?, posted by Sammybabe on November 9, 2004, at 19:09:09

I pasted a summary of a study last year that compared Pamelor to Prozac. It found that age and gender made a difference.

I don't know a lot about TCA's, but I think that Pamelor's advantage is lower sexual side effects than Prozac or other SSRI's. The main disadvantage of Pamelor would be constipation. Doctors prefer SSRI's since they are safer than TCA's, especially in overdoses.

Since side effects and effectiveness vary among people, it's hard to predict which would work better. If I had to choose between sexual side effects and constipation, I think I would take the latter and drink a lot of water.

1: Acta Psychiatr Scand. 2003 Jul;108(1):20-3. Related Articles, Links

A differential response to nortriptyline and fluoxetine in melancholic depression: the importance of age and gender.

Joyce PR, Mulder RT, Luty SE, McKenzie JM, Rae AM.

Department of Psychological Medicine, Christchurch School of Medicine & Health Sciences, PO Box 4345, Christchurch, New Zealand. peter.joyce@chmeds.ac.nz

OBJECTIVE: To consider the impact of age and gender on the antidepressant response to nortriptyline and fluoxetine in melancholic depression. METHOD: Of 191 depressed patients, 113 met study criteria for melancholia. All patients were randomized to receive either fluoxetine or nortriptyline. Response rates, defined as an improvement of 60% or more on the Montgomery Asberg Depression Rating Scale over 6 weeks of antidepressant treatment on an intention to treat basis, were examined by age, and by age and gender. RESULTS: Melancholic depressed patients 40 years or older, especially men, had a markedly superior response to nortriptyline compared with fluoxetine. Conversely, melancholic depressed patients, age 18-24 years, especially women, had a markedly superior response to fluoxetine. CONCLUSION: Age and gender appear to be critical variables in understanding differential antidepressant responses to tricyclic antidepressants and selective serotonin reuptake inhibitors in melancholic depression.


> I just started this after a very unsuccessful long run of Effexor. Is Pamelor good? My doc said it was one of the older but stronger meds. Any side effects? weight gain? any advice is welcome.

 

Re: Anyone every try Pamelor / Nortriptyline?

Posted by phillipa on November 10, 2004, at 16:30:02

In reply to Re: Anyone every try Pamelor / Nortriptyline?, posted by Bill LL on November 10, 2004, at 10:10:58

I may be wrong, but I believe there is the potential for weight gain. It is not known whether this is due to feeling better or to the drug.


This is the end of the thread.


Show another thread

URL of post in thread:


Psycho-Babble Medication | Extras | FAQ


[dr. bob] Dr. Bob is Robert Hsiung, MD, bob@dr-bob.org

Script revised: February 4, 2008
URL: http://www.dr-bob.org/cgi-bin/pb/mget.pl
Copyright 2006-17 Robert Hsiung.
Owned and operated by Dr. Bob LLC and not the University of Chicago.